Many businessmen even in Asia have a lot of reasons to feel energized at the opportunities lying ahead. Visions for the future according to Asiaweek suggests that dawn is just breaking on the bio-economy era. That health care may likely take the form of genetic interventions to prevent problems, vaccines will come in the shape of fruit and spare body parts could be grown from stem cells. Many Asian country companies, including those in Japan, Singapore, Taiwan, Korea sand India have already started investing in Gene study or genomics of Asian populations so that they can design better drugs and offer customized treatments for many diseases. Some are developing important partnerships with US companies.
China leads the latter field since it is driven by internal needs.
Recent news has indicated that pest resistant genetically modified rice is performing much better than control varieties. These are also called gene chips, DNA chips or microarrays. These are glass or silicon-based minute chips on which DNA from specific organisms can be permanently embedded and analyzed repeatedly using fluorescent DNA or RNA tags. The tags are monitored by scanning with lasers and computers. The latter may already contain data on a lot of sequence information, which allows one to analyze the new data obtained from the laser scan.